Prospective Randomized Trial of Bactrim on 7 Day Outcome in Patients With Uncomplicated Abscesses
Completed · Phase 3 · Has a placebo group
Conditions studied: Abscesses
In brief
Patients will be enrolled in a multi-center study to prospectively evaluate outcome after treatment for an uncomplicated skin abscess. All patients will receive incision and drainage and wound cultures. Patients will then be randomized to 1) placebo two tablets PO BID X 7 days or 2) bactrim DS (800/160) two tablets PO BID x 7 days. Patients will then return to the emergency department ED) at 48 hours and 7 for wound repacking and evaluation. The primary outcome is treatment failure rates at 7 days after incision and drainage. Patients who are clinically worsening or not improving after 48 hours will then be treated with additional antibiotics or admission if needed. Data will be analyzed both by initial randomization and intention to treat.
Key facts
- Study ID
- NCT00973765
- Run by
- 59th Medical Wing
- People needed
- 212
- Starts
- 2007-11-01
- Expected to finish
- 2009-08-01
- Last updated by the study team
- 2010-03-09
Who can join
Age: 16 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Inclusion criteria include all patients age 16 and older who present to the emergency department with a skin abscess that requires incision and drainage.
You may not qualify if…
- Exclusion criteria include patients with diabetes, HIV, cancer or other immunocompromised patients.
- Additionally, any patients who received antibiotics within one week of presentation or were hospitalized in previous month will be excluded to minimize potential confounding variables.
- Pregnant and breastfeeding patients will also be excluded due to possible safety concerns with antibiotic treatment.
- Patients with abscesses on face, perirectal, or perianal regions, abscesses with known tracks or fistulas to deeper structures, or abscesses requiring surgical drainage in an operating room are excluded.
- Patients with fever or evidence of systemic infection
- Finally, patients with sulfa allergy will be excluded.
Where it is running
- Wilford Hall Medical Center — Lackland Air Force Base, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.